SNMMI: PET spotlights link between Down syndrome, Alzheimer's
June 25, 2019 -- ANAHEIM, CA - Researchers are reporting early success in adapting a new method of calculating beta-amyloid accumulation, as seen in PET scans, for people with Down syndrome. Study results were presented on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Read More
Video from SNMMI 2019: Dr. Barry Siegel on PET reimbursement
June 25, 2019 -- ANAHEIM, CA - Having a lecture at a prominent medical conference named after you is a major honor for any physician. Delivering the inaugural eponymous lecture at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual conference, Dr. Barry Siegel addressed PET reimbursement. Read More
Video from SNMMI 2019: Outreach needed to tell discipline's story
June 25, 2019 -- ANAHEIM, CA - More outreach is needed to explain the value of nuclear medicine and molecular imaging, according to Dr. Vasken Dilsizian, incoming president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for the 2019-2020 term, in a video interview at this week's annual conference. Read More
SNMMI announces leadership slate for 2019-2020
June 25, 2019 -- ANAHEIM, CA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announced its leadership slate for the 2019-2020 term, with Dr. Vasken Dilsizian taking over as president and Alan Packard, PhD, serving as president-elect. Read More
SNMMI: PET ligand can diagnose brain disorder before autopsy
June 24, 2019 -- ANAHEIM, CA - Researchers have developed a tau PET radioligand that can accurately differentiate in vivo between progressive supranuclear palsy and similar brain disorders, according to a study presented Saturday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Read More
SNMMI: Technetium radiotracer tracks rheumatoid arthritis
June 24, 2019 -- ANAHEIM, CA - New findings on a technetium-based radiopharmaceutical that could be useful for monitoring rheumatoid arthritis by tracking joint inflammation were presented on Sunday at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) annual conference. Read More
SNMMI: FDG-PET/MRI improves pain diagnosis, management
June 24, 2019 -- ANAHEIM, CA - By identifying increased metabolic activity or inflammation associated with chronic pain, FDG-PET/MRI can improve care management strategies for a majority of patients, according to a study presented Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Read More
SNMMI: PSMA-PET helps guide prostate cancer therapy
June 23, 2019 -- ANAHEIM, CA - Adding an interim prostate-specific membrane antigen (PSMA)-PET scan during therapy can help guide treatment for patients with prostate cancer, according to a study presented Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. Read More
Special Feature
Nuclear medicine guidelines promote COVID-19 safety

How can nuclear medicine departments keep patients and staff safe during the COVID-19 pandemic? A new set of guidelines from the IAEA provides some guidance.. Read more